Summary Background In children, SARS-CoV-2 infection is usually asymptomatic or causes
a mild illness of short duration. Persistent illness has been reported; however, its prevalence …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

The COVID-19 vaccine is now approved for individuals greater than 5 years of age, but
vaccination rates remain lower than expected in the pediatric age group. Misinformation and …

Importance Severe outcomes among youths with SARS-CoV-2 infections are poorly
characterized. Objective To estimate the proportion of children with severe outcomes within …

Purpose This cross-sectional study was conducted to assess the parents' willingness to
vaccinate their children with the COVID-19 vaccine and related determinants with specific …

Importance Concerns have been raised that the use of antipsychotic medication for people
living with dementia might have increased during the COVID-19 pandemic. Objective To …

Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …

Objective To describe the infrastructure, tools, and services developed at Stanford Medicine
to maintain its data science ecosystem and research patient data repository for clinical and …

Mengchun Gong, a, b* Yuanshi Jiao, c Yang Gong, d and Li Liu a aNanfang Hospital,
Southern Medical University, Guangzhou, China bInstitute of Health Management, Southern …

Purpose The primary aim of this work was to convert the Information System for Research in
Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes …